1997
DOI: 10.1074/jbc.272.11.6827
|View full text |Cite
|
Sign up to set email alerts
|

The Biologic Action of Single-chain Choriogonadotropin Is Not Dependent on the Individual Disulfide Bonds of the β Subunit

Abstract: Disrupting disulfide loops in the human chorionic gonadotropin ␤ subunit (CG␤) inhibits combination with the ␣ subunit. Because the bioactivity requires a heterodimer, studies on the role of disulfide bonds on receptor binding/signal transduction have previously been precluded. To address this problem, we bypassed the assembly step and genetically fused CG␤ subunits bearing paired cysteine mutations to a wild-type ␣ (WT␣) subunit. The changes altered secretion of the single-chain mutants which parallel that se… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
31
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 35 publications
(37 citation statements)
references
References 30 publications
6
31
0
Order By: Relevance
“…In the large family of CSH domains, it is observed that a variety of disulfide-bonding patterns can be tolerated within the core of the domain, providing a structural scaffold that orients the ␣-helix on the surface (41). Thus, the curious retention of PAI-1 binding among this set of clearly different folds for the SMB domain is consistent with the demonstrated malleability of cystine knot structures to accommodate cysteine substitutions, yet retain activity (41)(42)(43)(44)(45). Even though the recombinant forms of the SMB domain do not have the correct cystine bonds found in circulating vitronectin, PAI-1 binding appears to be maintained because the various disulfide cross-linked frameworks support the formation of the sole ␣-helix in this domain.…”
Section: Figmentioning
confidence: 63%
“…In the large family of CSH domains, it is observed that a variety of disulfide-bonding patterns can be tolerated within the core of the domain, providing a structural scaffold that orients the ␣-helix on the surface (41). Thus, the curious retention of PAI-1 binding among this set of clearly different folds for the SMB domain is consistent with the demonstrated malleability of cystine knot structures to accommodate cysteine substitutions, yet retain activity (41)(42)(43)(44)(45). Even though the recombinant forms of the SMB domain do not have the correct cystine bonds found in circulating vitronectin, PAI-1 binding appears to be maintained because the various disulfide cross-linked frameworks support the formation of the sole ␣-helix in this domain.…”
Section: Figmentioning
confidence: 63%
“…The generation of variants in the presence or absence of a linker sequence to space the tethered subunit domains, as well as switching their relative position, enabled to generate SC gonadotropin analogs with differences in the conformation (Argos, 1990;Ben-Menahem et al, 2001Garcia-Campayo and Boime, 2001;Grinberg et al, 2008;Sugahara et al, 1995Sugahara et al, , 1996b. Interestingly, gonadotropin analogs, mostly SC variants but also mutated heterodimers and nonpeptide mimetics, with a conformation that is different from that of the wild-type heterodimer, bound to the cognate receptor and stimulated cAMP formation, which is a key signaling mediator for steroidogenesis (Ben-Menahem et al, 1997;Fralish et al, 2003;Garcia-Campayo and Boime, 2001;Grossmann et al, 1997;Heikoop et al, 1997;Jackson et al, 1999;Maclean et al, 2004;Moyle et al, 1987;Perlman et al, 2003;Sato et al, 1997;Sugahara et al, 1995;van Straten et al, 2002;Weenen et al, 2004;Xing et al, 2001). These and additional studies indicated that not all the interactions between the a and b subunits as seen in the crystal structure of the heterodimer are mandatory for receptor binding and activation (Bhowmick et al, 1996;Fan and Hendrickson, 2005;Fox et al, 2001;Lapthorn et al, 1994).…”
Section: Introductionmentioning
confidence: 97%
“…The curve for ␣E56C-␤C26A, which is between those for hCG and ␣L41C-␤C26A is not shown. chain gonadotropin analogs have also led to the suggestion that the region of the seatbelt near the latch disulfide is not needed for lutropin activity (29,30,32). Although this conclusion is consistent with the data described here, the finding that a single-chain hCG analog lacking this disulfide was recognized well by B111 (hCGsc␤C26A, C110A-␣, Table I) suggests that fusing the subunits together offsets the role of the seatbelt latch disulfide in stabilizing this region of the protein.…”
Section: Fig 5 Abilities Of Selected Analogsmentioning
confidence: 99%
“…This result confirmed that the carboxyl-terminal end of the seatbelt in all the mutant analogs occupies a position different from that in hCG. Others have shown that the disulfide between ␤-subunit residues 26 and 110 that latches the ␤-subunit is not required for hormone folding or for receptor binding activities of single-chain analogs (29,30). To learn if the carboxyl-terminal end of the seatbelt has a similar location in a single-chain hCG analog lacking the seatbelt latch disulfide as it has in hCG, we compared hCGsc␤C26A, C110A-␣ (Fig.…”
Section: The Position Of the Seatbelt In These Cross-linked Heterodimmentioning
confidence: 99%
See 1 more Smart Citation